NRX PHARMACEUTICALS, INC.

(NRXP)
  Rapport
Temps Différé Nasdaq  -  22:00 12/08/2022
0.7997 USD   -0.97%
02/08VENTE D'INITIÉS : NRX Pharmaceuticals
MT
13/07NRX Pharmaceuticals nomme Stephen Willard au poste de PDG
MT
13/07NRx Pharmaceuticals, Inc. annonce la nomination de Stephen Willard au poste de chef de la direction
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur NRX PHARMACEUTICALS, INC.
12/08NRX PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition ..
12/08NRX PHARMACEUTICALS : Non-Reliance on Previously Issued Financial Statements and Completed..
12/08NRX PHARMACEUTICALS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review ..
10/08/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
02/08INSIDER SELL : NRX Pharmaceuticals
28/07NRX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
21/07NRX PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
15/07NRX PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing ..
15/07NRX PHARMACEUTICALS : Announces the Appointment of Stephen Willard, Chief Executive Office..
13/07NRX Pharmaceuticals Names Stephen Willard CEO
13/07NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Offic..
13/07NRx Pharmaceuticals, Inc. Announces the Appointment of Stephen Willard as its Chief Exe..
13/07NRx Pharmaceuticals Announces the Appointment of Stephen Willard as Member of the Compa..
04/07Relief Therapeutics Partner NRx Receives US FDA's Emergency Use Rejection For Aviptadil
01/07Relief-Partner NRx scheitert mit US-Antrag auf Notfallzulassung für Zyesami
01/07NRx Pharma Shares Slip After FDA Declines EUA for Zyesami in Subgroup of Covid Patients
01/07NRx Pharmaceuticals Says FDA Declines Emergency Use Authorization for COVID-19-Driven R..
01/07FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patie..
01/07Nrx Pharmaceuticals, Inc. Announces FDA Declines Emergency Use Authorization for Zyesam..
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell Microcap Growth Index
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell Microcap Value Index
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell 3000E Index
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell Microcap Index
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell 3000E Growth Index
24/06NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to Russell 3000E Value Index
23/06NRX PHARMACEUTICALS LEADERS TO PRESE : Neuropsychiatry, Psychedelics, and Beyond
21/06Nrx Pharmaceuticals, Inc. Announces Director Resignation
13/06NRx Pharmaceuticals Down 8% After FDA Denies Breakthrough Therapy Designation
13/06NRx Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Denied for avipta..
11/06NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request f..
11/06NRx Pharmaceuticals, Inc. Provides Update on Breakthrough Therapy Designation Request f..
08/06NRX PHARMACEUTICALS : Appoints Seth Van Voorhees, PhD, as Chief Financial Officer and Trea..
08/06NRX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Other Events, Finan..
08/06NRx Pharmaceuticals Appoints Seth Van Voorhees Finance Chief
08/06NRx Pharmaceuticals Appoints Seth Van Voorhees as Chief Financial Officer, Effective Ju..
02/06INSIDER BUY : Nrx Pharmaceuticals
31/05NRX PHARMACEUTICALS : Announces Data Safety Monitoring Board (DSMB) Update on U.S. Nationa..
31/05NRX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
26/05Wall Street Set for Gains as Jobless Claims Data Point to Strong Labor Market
26/05SECTOR UPDATE : Health Care Stocks Steady Pre-Bell Thursday
26/05RELIEF : Datenüberwachungskomitee empfielt Einstellung der Aviptadil-Studien
26/05SECTOR UPDATE : Health Care
26/05Relief Therapeutics' Partners Receives Review For COVID-19 Drug Trial
26/05Top Premarket Decliners
26/05NRx Pharmaceuticals Says Data Safety Board Recommends Halting Aviptadil Trial in Critic..
26/05NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. Nation..
26/05NRx Pharmaceuticals, Inc. Announces Data Safety Monitoring Board Update on U.S. Nationa..
25/05NRX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
25/05NRx Pharmaceuticals, Inc. Announces the Resignation of Ira Strassberg as Chief Financia..
25/05NRx Pharmaceuticals, Inc. Announces Executive Changes
19/05NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. Global Investment C..
16/05NRX PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition ..
16/05NRx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31..
16/05NRx Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial R..
12/05NRx Pharmaceuticals Enrolls First Patient in Phase 2 Bipolar Depression Study of NRX-10..
12/05NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar ..
12/05NRx Pharmaceuticals, Inc. Announces Enrollment of First Patient in Phase II Study of Bi..
10/05NRx Pharmaceuticals to Report First Quarter 2022 Results on May 16, 2022
22/04Relief Therapeutics Partner NRx Seeks US FDA's Breakthrough Therapy Designation For COV..
21/04NRx Pharmaceuticals Submits Breakthrough Therapy Designation Request for Aviptadil in P..
21/04Relief-Partner NRx stellt neuen Antrag auf Notfallzulassung für Zyesami
21/04NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI® (av..
21/04NRx Pharmaceuticals, Inc. Files New Breakthrough Therapy Designation Request for ZYESAM..
08/04NRx Pharmaceuticals' Interim CEO and other Leaders to Present at 21st Annual Needham Vi..
01/04Relief Therapeutics' Nebulized COVID-19 Drug Fails To Provide Clinical Benefit In Mid-s..
31/03NRX PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition ..
31/03NRx Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31,..
31/03I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests No Clinic..
31/03NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Resul..
31/03Quantum Leap Healthcare in Collaboration with NRx Pharmaceuticals Announce the Nebulize..
28/03NRx Pharmaceuticals to Report Year-End 2021 Results on March 31, 2022
21/03NRX PHARMACEUTICALS, INC.(NASDAQGM : NRXP) added to S&P Global BMI Index
18/03NRX PHARMACEUTICALS : Appoints Ira Strassberg asChief Financial Officer and Treasurer - Fo..
18/03NRX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Other Events, Finan..
18/03NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Treasurer
1  2  3  4  5  6Suiv.
Prochain événement sur NRX PHARMACEUTICALS, INC.